February 2017

Optogenerapy > 2017 > February

Barcelona 20th February, 2017 - Researchers from eleven institutions and companies in seven different European countries met at Eurecat’s facilities in Cerdanyola del Vallès (Barcelona) to launch the Optogenerapy project, which aims to develop optogenetic cellular therapy implants as a new treatment for Multiple Sclerosis.   The devices, based on technology developed at the Swiss Federal Institute of Technology in Basel, member of the consortium, will enable the...

Read More
Do NOT follow this link or you will be banned from the site!